To analyze efficacy and safety of pegfilgrastim versus filgrastim in patients with breast cancer

被引：0
|
作者：
Satheesh, C. T. [1 ]
Tejinder, S. [1 ]
Ankit, J. [1 ]
Sajeevan, K. V. [1 ]
Lakshmaiah, K. C. [1 ]
Lokanatha, D. [1 ]
Babu, K. Govind [1 ]
Suresh, T. M. [1 ]
机构：
[1] Kidai Mem Inst Oncol, Bangalore, Karnataka, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20587
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Balugrastim Compared With Pegfilgrastim in Patients With Breast Cancer Receiving Chemotherapy
    Volovat, Constantin
    Gladkov, Oleg A.
    Bondarenko, Igor M.
    Barash, Steve
    Buchner, Anton
    Bias, Peter
    Adar, Liat
    Avisar, Noa
    CLINICAL BREAST CANCER, 2014, 14 (02) : 101 - 108
  • [2] Cost utility analysis of primary prophylaxis with pegfilgrastim versus filgrastim for breast cancer in the UK
    Booth, P.
    Dubois, R.
    Doan, Q., V
    Liu, Z.
    VALUE IN HEALTH, 2006, 9 (06) : A289 - A289
  • [3] Cost-effectiveness of pegfilgrastim versus six days of filgrastim for preventing febrile neutropenia in breast cancer patients
    Danova, Marco
    Chiroli, Silvia
    Rosti, Giovanni
    Doan, Quan V.
    TUMORI JOURNAL, 2009, 95 (02): : 219 - 226
  • [4] EFFICACY AND SAFETY OF BALUGRASTIM COMPARED WITH PEGFILGRASTIM IN PATIENTS WITH BREAST CANCER WHO ARE RECEIVING CHEMOTHERAPY
    Udo, M.
    Volovat, C.
    Gladkov, O.
    Bondarenko, I.
    Barash, S.
    Buchner, A.
    Avisar, N.
    Bias, P.
    HAEMATOLOGICA, 2012, 97 : 47 - 47
  • [5] EFFICACY AND SAFETY OF LIPEGFILGRASTIM COMPARED WITH PEGFILGRASTIM IN PATIENTS WITH BREAST CANCER WHO ARE RECEIVING CHEMOTHERAPY
    Udo, M.
    Bondarenko, I.
    Gladkov, O.
    Elaesser, R.
    Buchner, A.
    Bias, P.
    HAEMATOLOGICA, 2012, 97 : 553 - 553
  • [6] Efficacy and safety of balugrastim compared with pegfilgrastim in patients with breast cancer who are receiving chemotherapy.
    Volovat, Constantin D.
    Gladkov, Oleg
    Bondarenko, Igor
    Barash, Steven
    Buchner, Anton
    Avisar, Noa
    Bias, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Efficacy and safety of pegfilgrastim in prophylaxis of chemotherapy-induced neutropenia in breast cancer patients.
    Xia, Wen
    Xu, Fei
    Yuan, Zhongyu
    Xu, Ruilian
    Jiang, Yi
    Wu, Zhiyong
    Lu, Qianyi
    Zheng, Qiufan
    Hong, Ruoxi
    Jiang, Kuikui
    Huang, Jiajia
    An, Xin
    Bi, XiWen
    Hong, Yun
    Pang, Danmei
    Zhang, Anqin
    Wang, Xianming
    Zhang, Qing
    Zhang, Haibo
    Wang, Shusen
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Efficacy and safety of lipegfilgrastim compared with pegfilgrastim in patients with breast cancer who are receiving chemotherapy.
    Bondarenko, Igor
    Gladkov, Oleg
    Elaesser, Reiner
    Buchner, Anton
    Bias, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] The Economic Value of Primary Prophylaxis Using Pegfilgrastim Compared with Filgrastim in Patients with Breast Cancer in the UK
    Liu, Zhimei
    Doan, Quan
    Malin, Jennifer
    Leonard, Robert
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2009, 7 (03) : 193 - 205
  • [10] Safety of same day administration of pegfilgrastim in breast cancer patients
    Reynolds, Kathryn
    Katz, Julia
    Nabell, Lisle
    Grant, Stefan C.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345